Companies
Cathay Industrial Biotech
Cathay engineers microbes to produce long-chain dibasic acids, a class of biobased monomers for polymers and lubricants, and is a flagship of China's industrial-synbio push.
- Country
- China
Commercial
Public (SSE STAR)
Coverage
| CN | EU | US | |
|---|---|---|---|
| genome-engineering | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $135M in financing from Shanxi Lu'an Mining (Group) Co. Ltd. (December 2015) | fuelsandlubes.com |
| Capacity | 75 kt/a long-chain diacids, 50 kt/a pentanediamine, and 100 kt bio-based polyamides (current capacity) | cathaybiotech.com · sse.com.cn |
| Production site | Jinxiang and Wusu, China; Taiyuan, China (under construction) | cathaybiotech.com |
| Revenue | 2.958 billion yuan (2024) | news.futunn.com |
| Headcount | 1,735 employees | futunn.com |
Independent sources: cathaybiotech.com · fuelsandlubes.com · futunn.com · news.futunn.com · sse.com.cn
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Synthetic biology | genome-engineering | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.